Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 55154-4166

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 55154-4166). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Bag Label (1272aada 9a5b 4397 Bb65 9398927aa325 00)

Bag Label (1272aada 9a5b 4397 Bb65 9398927aa325 00)
Label for ATORVASTATIN CALCIUM 40 mg film-coated tablets, package of 10 tablets. The label includes storage instructions, prescription status (RX only), and warns that this unit dose package is not child resistant. Manufactured by Apotex Inc., Canada, and distributed by Major Pharmaceuticals and Cardinal Health. Barcode and lot number L118 also visible.*
FDA Label Image

Figure-01 (Figure 01)

Figure-01 (Figure 01)
A line graph showing cumulative incidence percentage over time in years up to 3.5 years for two groups: Atorvastatin and placebo. The Atorvastatin group has a lower cumulative incidence compared to placebo, with a hazard ratio of 0.64 (95% CI 0.50-0.83) and a p-value of 0.0005 indicated on the graph.*
FDA Label Image

Figure-02 (Figure 02)

Figure-02 (Figure 02)
A line graph showing cumulative hazard percentage over time (years) comparing Atorvastatin to placebo. The x-axis represents time to first primary endpoint through four years of follow-up, and the y-axis represents cumulative hazard percentage. The graph includes a hazard ratio (HR) of 0.63 with confidence intervals and a p-value.*
FDA Label Image

Figure-03 (Figure 03)

Figure-03 (Figure 03)
A line graph depicting the percentage of subjects experiencing a cardiovascular event over time for Atorvastatin 10 mg and 80 mg. The graph shows time in years on the x-axis and subjects experiencing events on the y-axis, comparing event occurrence between the two dosages over a 5-year period.*
FDA Label Image

Chemical-structure (Chemical Structure)

Chemical-structure (Chemical Structure)
Chemical structure diagram of atorvastatin calcium, the active ingredient in the ATORVASTATIN CALCIUM 40 mg film-coated tablet. The image shows the molecular arrangement including calcium ions associated with the compound.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.